Loading...
XSHE
002696
Market cap348mUSD
Dec 05, Last price  
7.11CNY
1D
2.75%
1Q
12.68%
Jan 2017
-45.69%
IPO
-4.57%
Name

Baiyang Investment Group Inc

Chart & Performance

D1W1MN
XSHE:002696 chart
P/E
P/S
0.80
EPS
Div Yield, %
Shrs. gr., 5y
1.77%
Rev. gr., 5y
1.59%
Revenues
3.08b
+13.14%
412,115,123449,703,724770,175,0151,012,897,7051,170,783,8461,349,625,9141,780,815,0511,863,739,4602,068,525,0792,394,128,7573,133,583,9022,844,133,7342,482,574,2472,905,284,8463,213,988,7432,720,215,7253,077,701,423
Net income
-15m
L-44.72%
29,044,64137,574,14446,298,29664,816,28584,644,68856,876,81956,403,39857,078,38959,255,873113,199,85457,140,621022,265,13926,831,58962,338,831-27,593,739-15,254,206
CFO
-60m
L
010,797,83848,880,31999,335,53152,609,576100,308,137073,221,44678,422,269319,831,82491,955,431348,630,39634,734,5700176,602,946242,523,596-60,177,737
Dividend
Jul 09, 20190.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Baiyang Investment Group, Inc., together with its subsidiaries, operates in the aquaculture industry in China. The company is involved in aquatic research and development, aquatic fry breeding, feedstuff production, fish farming, aquatic products processing, and gelatine and other biological products production activities. It offers tilapia, shrimp, and grass carp products; and collagen and gelatin biological products for use in the food, beauty, health care, and biomedicine fields. The company also supplies seeds for tilapia farmers; and specializes in the research, development, manufacture, and sale of fish, shrimp, and frog feeds. In addition, it exports its aquatic products to the United States, Russia, Mexico, Canada, the European Union, the Middle East, and internationally. The company was formerly known as Baiyang Aquatic Group, Inc. and changed its name to Baiyang Investment Group, Inc. in November 2015. Baiyang Investment Group, Inc. was founded in 2000 and is headquartered in Nanning, China.
IPO date
Sep 05, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT